These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36090643)

  • 41. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
    Hao Z; Liang H; Zhang Y; Wei W; Lan Y; Qiu S; Lin G; Wang R; Liu Y; Chen Y; Huang J; Wang W; Cui F; Goto T; Jeong JY; Veronesi G; Lopez-Pastorini A; Igai H; Liang W; He J; Liu J
    Transl Lung Cancer Res; 2021 Mar; 10(3):1408-1423. PubMed ID: 33889519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
    Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
    Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.
    Aggarwal C; Li L; Borghaei H; Mehra R; Somaiah N; Turaka A; Langer CJ; Simon GR
    Cancer Control; 2014 Jan; 21(1):57-62. PubMed ID: 24357742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database.
    Li J; Zeng Z; Huang Z; Gong Y; Xie C
    J Oncol; 2022; 2022():6280538. PubMed ID: 35761902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of surgery in a case-control study of patients with clinical stage IIIA small cell lung cancer.
    Li S; Jin K; Pan Y; Wu C; Ren S; Jiang G; Zhang P
    J Thorac Dis; 2021 May; 13(5):2738-2745. PubMed ID: 34164166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study.
    Rao H; Zhou S; Mei A; Yao A; Xie S
    Aging (Albany NY); 2022 Jun; 14(11):4827-4838. PubMed ID: 35680571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis.
    Lang C; Egger F; Alireza Hoda M; Saeed Querner A; Ferencz B; Lungu V; Szegedi R; Bogyo L; Torok K; Oberndorfer F; Klikovits T; Schwendenwein A; Boettiger K; Renyi-Vamos F; Hoetzenecker K; Schelch K; Megyesfalvi Z; Dome B
    Lung Cancer; 2022 Jul; 169():40-46. PubMed ID: 35643059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Yang H; Mei T
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
    Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
    Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of surgery and prophylactic cranial irradiation in stage II and III small cell lung cancer.
    Yin K; Song D; Zhang H; Cai F; Chen J; Dang J
    J Cancer; 2018; 9(19):3500-3506. PubMed ID: 30310506
    [No Abstract]   [Full Text] [Related]  

  • 51. Retrospective study of surgical resection in the treatment of limited stage small cell lung cancer.
    Zheng Q; Li S; Zhang L; Wu N; Chen J; Wang Y; Yan S; Zhao B; Yao Y; Pei Y; Ma Y; Yang Y
    Thorac Cancer; 2013 Nov; 4(4):395-399. PubMed ID: 28920219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of surgery in patients with early stage small-cell lung cancer.
    Peng A; Li G; Xiong M; Xie S; Wang C
    Cancer Manag Res; 2019; 11():7089-7101. PubMed ID: 31440096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis.
    Xu J; He T; Wu Y; Cao J; Han X; Liu L; Fu X; Li Y; Li X; Xu L; Liu Y; Zhao H; Liu D; Peng X; Hu J
    Clin Lung Cancer; 2022 Mar; 23(2):170-176. PubMed ID: 34281774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
    Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
    Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Analysis of Limited Resection Versus Lobectomy in Stage IA Small Cell Lung Cancer Patients Based on the Surveillance, Epidemiology, and End Results Registry Database.
    Gu C; Huang Z; Dai C; Wang Y; Ren Y; She Y; Su H; Chen C
    Front Genet; 2018; 9():568. PubMed ID: 30524472
    [No Abstract]   [Full Text] [Related]  

  • 58. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
    Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
    Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.
    Yang CJ; Chan DY; Speicher PJ; Gulack BC; Tong BC; Hartwig MG; Kelsey CR; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2017 Jun; 103(6):1767-1772. PubMed ID: 28385378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.